Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001562230-19-000036
Filing Date
2019-05-10
Accepted
2019-05-10 13:22:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A edgsgen.txt SC 13G/A 7228
  Complete submission text file 0001562230-19-000036.txt   8842
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Subject) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-61317 | Film No.: 19813964
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 333 S. HOPE STREET LOS ANGELES CA 90071
Business Address 333 S. HOPE STREET LOS ANGELES CA 90071 213-486-9200
Capital International Investors (Filed by) CIK: 0001562230 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A